<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD02280000_2</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P60891</UniProt_ID>
  <Seq_Length>318</Seq_Length>
  <Molecule_Weight>34834</Molecule_Weight>
  <KEGG_ID>hsa:5631</KEGG_ID>
  <Orthology_ID>K00948</Orthology_ID>
  <Function_Summary>Catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) that is essential for nucleotide synthesis.</Function_Summary>
  <Catalytic_Mechanism>ATP + D-ribose 5-phosphate = AMP + 5-phospho-alpha-D-ribose 1-diphosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF00156:Pribosyltran</Pfam_ID>
  <Allosteric_Activator_Count>2</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>2</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>1</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>PPRibP</Alias>
      <Alias>Ribose-phosphate pyrophosphokinase 1</Alias>
      <Alias>PRS-I</Alias>
      <Alias>Phosphoribosyl pyrophosphate synthase I</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with magnesium (Mg) ions.</Detail>
      <Keyword>Magnesium ion binding</Keyword>
      <Ontology_ID>GO:0000287</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: D-ribose 5-phosphate + ATP = 5-phospho-alpha-D-ribose 1-diphosphate + AMP + 2 H(+).</Detail>
      <Keyword>Ribose phosphate diphosphokinase activity</Keyword>
      <Ontology_ID>GO:0004749</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activity</Keyword>
      <Ontology_ID>GO:0016301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein to form a homodimer.</Detail>
      <Keyword>Protein homodimerization activity</Keyword>
      <Ontology_ID>GO:0042803</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>152</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>193</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>203</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>290</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>231</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>87</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>115</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>306</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>190</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>114</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>183</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>65</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Gln</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>52</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>43</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>129</Position>
      <Original>Leu</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>219</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.</Detail>
      <Keyword>Nervous system development</Keyword>
      <Ontology_ID>GO:0007399</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.</Detail>
      <Keyword>Purine nucleotide biosynthetic process</Keyword>
      <Ontology_ID>GO:0006164</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of 5-phosphoribose 1-diphosphate, also known as 5-phosphoribosyl-1-pyrophosphate.</Detail>
      <Keyword>5-phosphoribose 1-diphosphate biosynthetic process</Keyword>
      <Ontology_ID>GO:0006015</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of urate, the anion of uric acid, 2,6,8-trioxypurine.</Detail>
      <Keyword>Urate biosynthetic process</Keyword>
      <Ontology_ID>GO:0034418</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of hypoxanthine, 6-hydroxy purine, an intermediate in the degradation of adenylate. Its ribonucleoside is known as inosine and its ribonucleotide as inosinate.</Detail>
      <Keyword>Hypoxanthine biosynthetic process</Keyword>
      <Ontology_ID>GO:0046101</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of a ribonucleoside monophosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with phosphate on the sugar.</Detail>
      <Keyword>Ribonucleoside monophosphate biosynthetic process</Keyword>
      <Ontology_ID>GO:0009156</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving a nucleoside, a nucleobase linked to either beta-D-ribofuranose (a ribonucleoside) or 2-deoxy-beta-D-ribofuranose, (a deoxyribonucleoside), e.g. adenosine, guanosine, inosine, cytidine, uridine and deoxyadenosine, deoxyguanosine, deoxycytidine and thymidine (= deoxythymidine).</Detail>
      <Keyword>Nucleoside metabolic process</Keyword>
      <Ontology_ID>GO:0009116</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates).</Detail>
      <Keyword>Nucleotide biosynthetic process</Keyword>
      <Ontology_ID>GO:0009165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of a pyrimidine nucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.</Detail>
      <Keyword>Pyrimidine nucleotide biosynthetic process</Keyword>
      <Ontology_ID>GO:0006221</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPL</Protein_Seq>
    <DNA_Seq>GACTTCGGTTCCGGTCTCTGCAGCAGCCGTGATCGCTTAGTGGAGTGCTTAGGGTAGTTGGCCAGGATGCCGAATATCAAAATCTTCAGCGGCAGTTCCCACCAGGACTTATCTCAGAAAATTGCTGACCGCCTGGGCCTGGAGCTAGGCAAGGTGGTGACTAAGAAGTTCAGCAACCAGGAGACCTGTGTGGAAATCGGTGAAAGTGTACGTGGAGAGGATGTCTACATTGTTCAGAGTGGTTGTGGCGAAATCAATGACAATTTAATGGAGCTTTTGATCATGATTAATGCCTGCAAGATTGCTTCAGCCAGCCGGGTTACTGCAGTCATCCCATGCTTCCCTTATGCCCGGCAGGATAAGAAGGATAAGAGCCGGGCGCCAATCTCAGCCAAGCTTGTTGCAAATATGCTATCTGTAGCAGGTGCAGATCATATTATCACCATGGACCTACATGCTTCTCAAATTCAGGGCTTTTTTGATATCCCAGTAGACAATTTGTATGCAGAGCCGGCTGTCCTAAAGTGGATAAGGGAGAATATCTCTGAGTGGAGGAACTGCACTATTGTCTCACCTGATGCTGGTGGAGCTAAGAGAGTGACCTCCATTGCAGACAGGCTGAATGTGGACTTTGCCTTGATTCACAAAGAACGGAAGAAGGCCAATGAAGTGGACCGCATGGTGCTTGTGGGAGATGTGAAGGATCGGGTGGCCATCCTTGTGGATGACATGGCTGACACTTGTGGCACAATCTGCCATGCAGCTGACAAACTTCTCTCAGCTGGCGCCACCAGAGTTTATGCCATCTTGACTCATGGAATCTTCTCCGGTCCTGCTATTTCTCGCATCAACAACGCATGCTTTGAGGCAGTAGTAGTCACCAATACCATACCTCAGGAGGACAAGATGAAGCATTGCTCCAAAATACAGGTGATTGACATCTCTATGATCCTTGCAGAAGCCATCAGGAGAACTCACAATGGAGAATCCGTTTCTTACCTATTCAGCCATGTCCCTTTATAATAGAGTAAGGTATTGATGACAAATTCAGCAGAAGACCCGGCTTGCTCCAGTGTAGCTTTCTACATCCCACATCAGGATATTAGAGGTTATCCGAACTGGGGAAAGACGGATTGAGATTAACTGCTGGACCTCCTACCTGCATTATCTCATTCTGGCTTCCTTGATAATTCTGT</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Widely expressed</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>PRPS1</Gene_Name>
    <Gene_ID>5631</Gene_ID>
    <Genbank_ACCN>NM_001204402</Genbank_ACCN>
    <Protein_ACCN>NP_001191331</Protein_ACCN>
    <HGNC_ID>9462</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/5631</Gene_URL>
    <UCSC_ID>uc004ene.4</UCSC_ID>
    <EMBL_ID>ENSG00000147224</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Deafness, X-Linked 1</Disease_Name>
      <Disease_Detail>Deafness</Disease_Detail>
      <Disease_DB>DFN194</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/deafness_x_linked_1?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Charcot-Marie-Tooth Disease</Disease_Name>
      <Disease_Detail>Charcot-Marie-Tooth Disease</Disease_Detail>
      <Disease_DB>CHR071</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/charcot_marie_tooth_disease?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Deafness, X-Linked 4</Disease_Name>
      <Disease_Detail>Deafness</Disease_Detail>
      <Disease_DB>DFN147</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/deafness_x_linked_4?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Charcot-Marie-Tooth Neuropathy X</Disease_Name>
      <Disease_Detail>Charcot-Marie-Tooth Disease</Disease_Detail>
      <Disease_DB>CHR316</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/charcot_marie_tooth_neuropathy_x?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lesch-Nyhan Syndrome</Disease_Name>
      <Disease_Detail>Lesch-Nyhan Syndrome</Disease_Detail>
      <Disease_DB>LSC001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lesch_nyhan_syndrome?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nonsyndromic Hearing Loss and Deafness</Disease_Name>
      <Disease_Detail>Nonsyndromic Hearing Loss and Deafness</Disease_Detail>
      <Disease_DB>NNS014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nonsyndromic_hearing_loss_and_deafness?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Severe Phosphoribosylpyrophosphate Synthetase Superactivity</Disease_Name>
      <Disease_Detail>Severe Phosphoribosylpyrophosphate Synthetase Superactivity</Disease_Detail>
      <Disease_DB>SVR064</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/severe_phosphoribosylpyrophosphate_synthetase_superactivity?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Charcot-Marie-Tooth Neuropathy X Type 5</Disease_Name>
      <Disease_Detail>Charcot-Marie-Tooth Disease</Disease_Detail>
      <Disease_DB>CHR121</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/charcot_marie_tooth_neuropathy_x_type_5?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prps1-Related Disorders</Disease_Name>
      <Disease_Detail>Prps1-Related Disorders</Disease_Detail>
      <Disease_DB>PRP049</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prps1_related_disorders?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Arts Syndrome</Disease_Name>
      <Disease_Detail>Arts Syndrome</Disease_Detail>
      <Disease_DB>ART002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/arts_syndrome?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Charcot-Marie-Tooth Hereditary Neuropathy</Disease_Name>
      <Disease_Detail>Charcot-Marie-Tooth Disease</Disease_Detail>
      <Disease_DB>CHR453</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/charcot_marie_tooth_hereditary_neuropathy?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Phosphoribosylpyrophosphate Synthetase Superactivity</Disease_Name>
      <Disease_Detail>Phosphoribosylpyrophosphate Synthetase Superactivity</Disease_Detail>
      <Disease_DB>PHS004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/phosphoribosylpyrophosphate_synthetase_superactivity?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mild Phosphoribosylpyrophosphate Synthetase Superactivity</Disease_Name>
      <Disease_Detail>Mild Phosphoribosylpyrophosphate Synthetase Superactivity</Disease_Detail>
      <Disease_DB>MLD015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mild_phosphoribosylpyrophosphate_synthetase_superactivity?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dfnx1 Nonsyndromic Hearing Loss and Deafness</Disease_Name>
      <Disease_Detail>Nonsyndromic Hearing Loss and Deafness</Disease_Detail>
      <Disease_DB>DFN002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dfnx1_nonsyndromic_hearing_loss_and_deafness?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Deafness, X-Linked 2</Disease_Name>
      <Disease_Detail>Deafness</Disease_Detail>
      <Disease_DB>DFN036</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/deafness_x_linked_2?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prps1-Related Charcot-Marie-Tooth Neuropathy X Type 5</Disease_Name>
      <Disease_Detail>Prps1-Related Disorders</Disease_Detail>
      <Disease_DB>PRP048</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prps1_related_charcot_marie_tooth_neuropathy_x_type_5?search=PRPS1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Charcot-Marie-Tooth Disease, X-Linked Recessive, 5</Disease_Name>
      <Disease_Detail>Charcot-Marie-Tooth Disease</Disease_Detail>
      <Disease_DB>CHR408</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/charcot_marie_tooth_disease_x_linked_recessive_5?search=PRPS1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>crystal structure of human phosphoribosyl pyrophosphate synthetase 1 in complex with AMP(ATP), cadmium and sulfate ion</PDB_Title>
      <PDB_ID>2HCR</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2HCR</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD02880002</ASD_Ligand>
      <Ligand_Name>SULFATE ION $ADENOSINE MONOPHOSPHATE</Ligand_Name>
      <PubMed_Title>Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.</PubMed_Title>
      <Author>Li S, et al.</Author>
      <Journal>(2007) Biochem.J. 401: 39-47</Journal>
      <PubMed_ID>16939420</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human phosphoribosyl pyrophosphate synthetase 1</PDB_Title>
      <PDB_ID>3EFH</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=3EFH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human phosphoribosyl pyrophosphate synthetase 1</PubMed_Title>
      <Author>Peng X, et al.</Author>
      <Journal>To be Published</Journal>
    </PDB>
    <PDB>
      <PDB_Title>2.0A Crystal structure of human phosphoribosyl pyrophosphate synthetase 1</PDB_Title>
      <PDB_ID>3S5J</PDB_ID>
      <Resolution>2.02</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3S5J</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD02880002</ASD_Ligand>
      <PubMed_Title>Crystal and EM Structures of Human Phosphoribosyl Pyrophosphate Synthase I (PRS1) Provide Novel Insights into the Disease-Associated Mutations</PubMed_Title>
      <Author>Chen, P., et al.</Author>
      <Journal>Plos One(2015)10:e0120304-e0120304</Journal>
      <PubMed_ID>25781187</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>crystal structure of human phosphoribosyl pyrophosphate synthetase 1 mutant S132A</PDB_Title>
      <PDB_ID>2H07</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2H07</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD02880002</ASD_Ligand>
      <Ligand_Name>SULFATE ION</Ligand_Name>
      <PubMed_Title>Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.</PubMed_Title>
      <Author>Li S, et al.</Author>
      <Journal>(2007) Biochem.J. 401: 39-47</Journal>
      <PubMed_ID>16939420</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>crystal structure of human phosphoribosyl pyrophosphate synthetase 1 mutant Y146M</PDB_Title>
      <PDB_ID>2H08</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2H08</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD02880002</ASD_Ligand>
      <Ligand_Name>SULFATE ION</Ligand_Name>
      <PubMed_Title>Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.</PubMed_Title>
      <Author>Li S, et al.</Author>
      <Journal>(2007) Biochem.J. 401: 39-47</Journal>
      <PubMed_ID>16939420</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human phosphoribosyl pyrophosphate synthetase 1</PDB_Title>
      <PDB_ID>2H06</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.rcsb.org/pdb/explore/explore.do?structureId=2H06</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD02880002</ASD_Ligand>
      <Ligand_Name>SULFATE ION</Ligand_Name>
      <PubMed_Title>Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.</PubMed_Title>
      <Author>Li S, et al.</Author>
      <Journal>(2007) Biochem.J. 401: 39-47</Journal>
      <PubMed_ID>16939420</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00030</Pathway_ID>
      <Pathway_Title>Pentose phosphate pathway</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01200</Pathway_ID>
      <Pathway_Title>Carbon metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00230</Pathway_ID>
      <Pathway_Title>Purine metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Nucleotide metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko01230</Pathway_ID>
      <Pathway_Title>Biosynthesis of amino acids</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Overview</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.ih.b.c.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/2h06</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,100,Lys;site,102,Lys;site,101,Asp;site,144,Asn;site,132,Ser;site,135,Gln;site,146,Tyr</Site_Detail>
      <Site_Reference>Li S, et al. Biochem.J. 2007,401(1):39-47.</Site_Reference>
      <Site_Type>Oligomerization</Site_Type>
      <PDB_ID>2H06;2H07;2H08;2HCR</PDB_ID>
      <PubMed_ID>16939420</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.6.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/6/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00370005</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00870006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01720026</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02280001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02880002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>